Experience

3-D Matrix EMEA

• France
• Medical Equipment Manufacturing
• 1 - 100 Employee

• Cardiology Sales Manager Europe, Middle East and Africa

  • Dec 2019 - Present

  My primary focus is cardiovascular sales both directly and via distributor networks in EMEA. Since the inception of 3-D Matrix as a spinoff from MIT in Massachusetts in 2004, 3-D Matrix has grown to become leading global peptide solutions company headquartered in Tokyo, Japan, with offices serving the Americas, Europe and Asia. PuraStat is a synthetic haemostatic material in the form of a prefilled syringe. It is indicated for haemostasis in the following situations encountered during surgery, when haemostasis by ligation or standard means is insufficient or impractical:Bleeding from small blood vessels and oozing from capillaries of the parenchyma of solid organsOozing from vascular anastomoses.Bleeding from small vessels and oozing from capillaries of the GI tract.Reduction of delayed bleeding following gastrointestinal endoscopic submucosal dissection (ESD) procedures in the colon.



Sequana Medical AG

• Country Manager UK

  • Aug 2018 - Oct 2019

  Sequana Medical is a commercial stage medical device company and an innovator in the management of liver disease. The first product, alfapump®, is a fully implantable, programmable, transcutaneously-charged, battery-powered pump for the management of refractory ascites (chronic fluid build-up in the abdomen).www.sequanamedical.comwww.alfapump.com Sequana Medical is a commercial stage medical device company and an innovator in the management of liver disease. The first product, alfapump®, is a fully implantable, programmable, transcutaneously-charged, battery-powered pump for the management of refractory ascites (chronic fluid build-up in the abdomen).www.sequanamedical.comwww.alfapump.com



PneumRx, Inc., a BTG International group company

• Country Manager UK, Ireland, Nordic Countries, Benelux & Italy

  • Aug 2013 - Aug 2018

  BTG have taken the decision to re-focus activities and concentrate on clinical studies with PneumRx to build long term value. Therefore the entire commercial operation has ceased to operate in its current format and the Sales and Marketing teams have been let go. My business was one of only 2 regions in the world that had significant growth year on year, which I believe in the current environment is a significant achievement. BTG have taken the decision to re-focus activities and concentrate on clinical studies with PneumRx to build long term value. Therefore the entire commercial operation has ceased to operate in its current format and the Sales and Marketing teams have been let go. My business was one of only 2 regions in the world that had significant growth year on year, which I believe in the current environment is a significant achievement.



STENTYS

• France
• Medical Devices
• 1 - 100 Employee

• UK Consultant & Owner of PLC

  • Feb 2013 - Aug 2013

  I worked as a Freelance Business Consultant primarily for Stentys in the field of Interventional Cardiology. Stentys are a Parisian based company that manufacture a Coronary Artery stent specifically designed for STEMI, Ectatic Vessels, Aneurysms, SVG's etc. Vascular Perspectives are a major UK distributor and I collaborated with them on a number of projects including the IDEV Supera Veritas Peripheral Vascular system, Asahi Guidewires and the Tryton Stent. I also worked with 2 other UK Private Limited Companies in the field of Critical Care/Oncology/Haematology. I am also the owner of a Private Limited Company, CD Vascular Innovations Ltd.



Tryton Medical, Inc

• United States
• Medical Equipment Manufacturing

• Sales Manager for Northern Europe

  • Nov 2011 - Feb 2013

  Back in the field of Interventional Cardiology I had responsibility for European Distributors plus management of KOL accounts in Northern Europe. Tryton specialise in unique Bifurcation Stents for the treatment of Coronary Artery Atherosclerosis.Unfortunately all VC funding was required for US launch so the entire European team had to be let go. I immediately began working with the UK distributor that I had been managing during my time at Tryton. It was at this point that I became independent and set up my PLC.



Fannin Ltd

• Ireland
• Medical Equipment Manufacturing
• 100 - 200 Employee

• National Sales Manager

  • Dec 2009 - Nov 2011

  responsibility for UK Critical Care Business with 10 direct reports, plus key Principle companies from both the US and Europe. Also responsible for P & L plus management of Key Opinion Leaders. responsibility for UK Critical Care Business with 10 direct reports, plus key Principle companies from both the US and Europe. Also responsible for P & L plus management of Key Opinion Leaders.



Johnson & Johnson

• Law Practice
• 1 - 100 Employee

• National Sales Manager Cordis

  • 2006 - 2009

  Managed the UK Sales Team selling range of specialised Interventional Cardiology products including DES, BMS, PTCA Balloons, Guidecaths etc. Responsible for development of European Key Competencies Project with dedicated team. Also launched 'Integrity Selling in the 21st Century' to the Sales Team Managed the UK Sales Team selling range of specialised Interventional Cardiology products including DES, BMS, PTCA Balloons, Guidecaths etc. Responsible for development of European Key Competencies Project with dedicated team. Also launched 'Integrity Selling in the 21st Century' to the Sales Team



VYGON

• France
• Medical Equipment Manufacturing
• 700 & Above Employee

• Regional Sales Manager

  • 1993 - 2006

  Lead, manage and coach a team of Account Managers and Senior Account Managers selling IV and Critical Care equipment. Chairman of National Senior Sales Assessment Course. Lead, manage and coach a team of Account Managers and Senior Account Managers selling IV and Critical Care equipment. Chairman of National Senior Sales Assessment Course.



Pall Corporation

• United States
• Manufacturing
• 700 & Above Employee

• Sales Executive

  • 1991 - 1993